Vimarsana
Biggest News Aggregation in the World

Page 13 - Low Dose News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Low Dose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Low Dose Today - Breaking & Trending Today

Fewer than 1 in 5 adults with Type 2 diabetes meet optimal health targets: Study - Vimarsana News

Fewer than 1 in 5 adults with Type 2 diabetes meet optimal health targets: Study

A new study has found that fewer than one in five adults with Type 2 diabetes in the US are meeting health targets to reduce heart disease risk.

Low-dose prednisolone effective for remission of lupus nephritis: Study - Vimarsana News

Low-dose prednisolone effective for remission of lupus nephritis: Study

Bangladesh: A low-dose prednisolone regimen may be effective for the treatment of proliferative lupus nephritis (LN), indicates a recent study published in the journal International Journal of...

Greene County resident collecting donations for Kentucky tornado victims - Vimarsana News

Greene County resident collecting donations for Kentucky tornado victims

Stacy Roach is collecting donations, but not just any kind.

FDA Panel OKs Low-Dose Pfizer COVID Vaccine for Children 5 and Up - Vimarsana News

FDA Panel OKs Low-Dose Pfizer COVID Vaccine for Children 5 and Up

A Food and Drug Administration advisory has approved the use of low-dose Pfizer's COVID vaccine for children 5- to 11-year-olds.

Pharnext: Data from First Phase III Clinical Study of PXT3003 in Charcot-Marie-Tooth Disease Type 1A, the PLEO-CMT Trial, Published in the Orphanet Journal of Rare Diseases - Vimarsana News

Pharnext: Data from First Phase III Clinical Study of PXT3003 in Charcot-Marie-Tooth Disease Type 1A, the PLEO-CMT Trial, Published in the Orphanet Journal of Rare Diseases

DJ Pharnext: Data from First Phase III Clinical Study of PXT3003 in Charcot-Marie-Tooth Disease Type 1A, the PLEO-CMT Trial, Published in the Orphanet Journal of Rare Diseases Pharnext Pharnext: Data